| Mr Michael Krogulecki, DO | |
|
1200 E Michigan Ave, Suite 370, Lansing, MI 48912-1800 | |
| (517) 484-4451 | |
| (517) 484-0291 |
| Full Name | Mr Michael Krogulecki |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 1200 E Michigan Ave, Lansing, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356336630 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 5101008920 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid Michigan Anesthesiology Group Pc | 3779680715 | 12 |
| Edward W Sparrow Hospital Association | 6709799166 | 522 |
News Archive
H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.
Since 2008, Cutting Edge Information has developed forecasting data for the diabetes treatment market. The new report - "Diabetes Market Forecast to 2015" - provides a deep analysis of the relevant clinical, commercial, and market trends affecting diabetes therapeutics today and their impact leading into the next decade. In addition to detailed drug, class, and company profiles, the study includes primary research findings generated from survey data and interviews with leading physicians and marketing executives.
The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.
In children and adults with Friedreich's ataxia, an inherited disease that causes damage to the nervous system, a loss of coordination typically progresses to muscle weakness and can involve vision, diabetes, and other problems over the course of several years.
Vitamin D supplements in early childhood may ward off the development of type 1 diabetes in later life, reveals a research review published ahead of print in the Archives of Disease in Childhood.
› Verified 6 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366498107 PECOS PAC ID: 6709799166 Enrollment ID: O20040311001138 |
News Archive
H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.
Since 2008, Cutting Edge Information has developed forecasting data for the diabetes treatment market. The new report - "Diabetes Market Forecast to 2015" - provides a deep analysis of the relevant clinical, commercial, and market trends affecting diabetes therapeutics today and their impact leading into the next decade. In addition to detailed drug, class, and company profiles, the study includes primary research findings generated from survey data and interviews with leading physicians and marketing executives.
The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.
In children and adults with Friedreich's ataxia, an inherited disease that causes damage to the nervous system, a loss of coordination typically progresses to muscle weakness and can involve vision, diabetes, and other problems over the course of several years.
Vitamin D supplements in early childhood may ward off the development of type 1 diabetes in later life, reveals a research review published ahead of print in the Archives of Disease in Childhood.
› Verified 6 days ago
| Entity Name | Mid Michigan Anesthesiology Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932131349 PECOS PAC ID: 3779680715 Enrollment ID: O20070525000318 |
News Archive
H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.
Since 2008, Cutting Edge Information has developed forecasting data for the diabetes treatment market. The new report - "Diabetes Market Forecast to 2015" - provides a deep analysis of the relevant clinical, commercial, and market trends affecting diabetes therapeutics today and their impact leading into the next decade. In addition to detailed drug, class, and company profiles, the study includes primary research findings generated from survey data and interviews with leading physicians and marketing executives.
The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.
In children and adults with Friedreich's ataxia, an inherited disease that causes damage to the nervous system, a loss of coordination typically progresses to muscle weakness and can involve vision, diabetes, and other problems over the course of several years.
Vitamin D supplements in early childhood may ward off the development of type 1 diabetes in later life, reveals a research review published ahead of print in the Archives of Disease in Childhood.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Krogulecki, DO 1200 E Michigan Ave, Suite 370, Lansing, MI 48912-1800 Ph: (517) 484-4451 | Mr Michael Krogulecki, DO 1200 E Michigan Ave, Suite 370, Lansing, MI 48912-1800 Ph: (517) 484-4451 |
News Archive
H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.
Since 2008, Cutting Edge Information has developed forecasting data for the diabetes treatment market. The new report - "Diabetes Market Forecast to 2015" - provides a deep analysis of the relevant clinical, commercial, and market trends affecting diabetes therapeutics today and their impact leading into the next decade. In addition to detailed drug, class, and company profiles, the study includes primary research findings generated from survey data and interviews with leading physicians and marketing executives.
The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.
In children and adults with Friedreich's ataxia, an inherited disease that causes damage to the nervous system, a loss of coordination typically progresses to muscle weakness and can involve vision, diabetes, and other problems over the course of several years.
Vitamin D supplements in early childhood may ward off the development of type 1 diabetes in later life, reveals a research review published ahead of print in the Archives of Disease in Childhood.
› Verified 6 days ago
Mr. Imu Amirali Esmail, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1200 E Michigan Ave, Suite 370, Lansing, MI 48912 Phone: 517-484-4451 Fax: 517-484-0291 | |
Dr. Angel Martino-horrall, MD Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 1215 E. Michigan Avenue, Lansing, MI 48912 Phone: 517-364-1000 Fax: 517-484-7377 | |
Byong-du W. Choi, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 608 W. Allegan St., 3rd Floor, Lansing, MI 48909 Phone: 517-702-5409 Fax: 517-702-5475 | |
Dr. Robert T Casimir, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 W Greenlawn Ave, Lansing, MI 48910 Phone: 832-279-2369 | |
Narasimha R. Gundamraj, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1540 Lake Lansing Rd, Suite G06, Lansing, MI 48912 Phone: 517-482-7246 Fax: 517-484-7377 | |
Dr. Michelle Kreft, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 W Greenlawn Ave, Lansing, MI 48910 Phone: 517-334-2195 | |
Candace Sue Metcalf, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-1000 Fax: 517-364-1000 |